Lidocaine is clinically widely used as a local anesthetic inhibiting propagation of action potentials in peripheral nerve fibers. Correspondingly, the functional magnetic resonance imaging (fMRI) response in mouse brain to peripheral noxious input is largely suppressed by local lidocaine administered at doses used in a clinical setting. We observed, however, that local administration of lidocaine at doses 100Â lower than that used clinically led to a significantly increased sensitivity of mice to noxious forepaw stimulation as revealed by fMRI. This hyperalgesic response could be confirmed by behavioral readouts using the von Frey filament test. The increased sensitivity was found to involve a type 1 cannabinoid (CB 1 ) receptor-dependent pathway as global CB 1 knockout mice, as well as wild-type mice pretreated systemically with the CB 1 receptor blocker rimonabant, did not display any hyperalgesic effects after low-dose lidocaine. Additional experiments with nociceptor-specific CB 1 receptor knockout mice indicated an involvement of the CB 1 receptors located on the nociceptors. We conclude that low concentrations of lidocaine leads to a sensitization of the nociceptors through a CB 1 receptor-dependent process. This lidocaine-induced sensitization might contribute to postoperative hyperalgesia. Ó
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Introduction
Sensory and nociceptive processing involves a network of neural structures, the first element being the nociceptor, a high threshold sensory neuron connecting peripheral tissues with the central nervous system (CNS) [41] . In the brain, nociceptive processing activates the ''pain matrix'' involving structures such as somatosensory, insular, cingulate, and prefrontal cortices, thalamus, and periaqueductal gray [3] . Functional magnetic resonance imaging (fMRI), assessing changes in cerebral blood oxygenation levels (BOLD [blood oxygen level-dependent] [35]), has been used for studying pain processing both in humans and animals, mostly in rats [8,11,27,29,31,32] but recently also in mice [1, 5, 18] . Mice are attractive, as transgenic lines may yield information on mechanisms underlying pain signaling. Substantial progress has been made in understanding the molecular mechanisms of normal or pathological pain states, much of it with the help of genetically engineered mice displaying altered sensitivity to noxious input [9,16,24,34].
Although sodium channel block and action potential inhibition by high concentrations of lidocaine are well established, effects of low concentrations are considerably more complex [28] and their effects on central pain processing have not been characterized in detail. fMRI can help to further elucidate effects of lidocaine on modulating sensory processing in response to peripheral noxious stimuli [28, 42] . It has been reported that lidocaine applied intravenously at low doses in rats enhances fMRI responses to acute nociceptive stimulation [28] . Several pharmacological effects could account for this increased sensitivity. In addition to inducing local anesthesia through blockade of voltage-gated sodium channels, lidocaine has been reported to inhibit tandem pore domain potassium channels [23] . Leffler et al. [25] showed that lidocaine directly activates and sensitizes the transient receptor potential channel 1 (TRPV1) located on C fibers and activated by noxious chemical or physical stimuli [10] .
We have applied fMRI in mice using an electrical forepaw stimulation paradigm [5] to study effects of lidocaine treatment
